verified SJR 1,709 · Q1 • database Scopus / SJR & Web of Science indexed

United Kingdom · Springer Nature

workspace_premium Q1 — Hematology lock Subscription

Bone Marrow Transplantation

Bone Marrow Transplantation is a journal indexed in SJR in Hematology and Transplantation with an H index of 149. It has a price of 3580 €. It has an SJR impact factor of 1,709 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,709.

Bone Marrow Transplantation focuses its scope in these topics and keywords: cell, stem, transplantation, patients, hematopoietic, allogeneic, blood, transplant, disease, conditioning, ...

ISSN: 0268-3369

Publisher: Springer Nature

Category: Hematology

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

1,709 Q1

H-index 149

Acceptance rate pie_chart

22% Selective

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

3.580 € Subscription

Non-OA path 0 €

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

1,709

H-index

149

Docs (year)

310

Docs 3y

1035

Total refs

8811

Cites 3y

3073

Citable 3y

608

Cites/Doc 2y

2.88

Ref/Doc

28.42

Immediate OA

3580 €

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Brentuximab vedotin in combination with or without donor lymphocyte infusion for patients with Hodgkin lymphoma after allogeneic stem cell transplantation

Will regulation be the death of cell therapy in the United States?

Cutaneous mucormycosis due to Absidia corymbifera occurring after bone marrow transplantation

Comparison of an enzyme immunoassay and a latex agglutination system for the diagnosis of invasive aspergillosis in bone marrow transplant recipients

Cokeromyces recurvatus infection in a bone marrow transplant recipient

CMV monitoring after peripheral blood stem cell and bone marrow transplantation by pp65 antigen and quantitative PCR

Clearance of erythrocyte allo-antibodies using Rituximab

Cidofovir for treating adenoviral hemorrhagic cystitis in hematopoietic stem cell transplant recipients

Cidofovir as primary pre-emptive therapy for post-transplant cytomegalovirus infections

Changing pattern of bacterial susceptibility to antibiotics in hematopoietic stem cell transplant recipients

Cell-mediated immune responses to influenza vaccination in healthy volunteers and allogeneic stem cell transplant recipients

Busulfan-based reduced intensity conditioning regimens for haploidentical transplantation in relapsed/refractory Hodgkin lymphoma: Spanish multicenter experience

SHOW MORE ARTICLES

Buccal swabs but not mouthwash samples can be used to obtain pretransplant DNA fingerprints from recipients of allogeneic bone marrow transplants

A randomized, multicenter study of G-CSF starting on day +1 vs day +5 after autologous peripheral blood progenitor cell transplantation

Bone marrow transplantation for chronic granulomatous disease: long-term follow-up and review of literature

Autologous stem cell transplantation for HIV-associated lymphoma in the antiretroviral and rituximab era: a retrospective study by the EBMT Lymphoma Working Party

Auto-SCT in refractory celiac disease type II patients unresponsive to cladribine therapy

Assessing agreement between CD34 enumeration by flow cytometry and volumetric analysis

Antibody and pre- plus post-transplant prednisone treatments support T cell-depleted stem cell engraftment without drug-induced morbidity

An outbreak of respiratory syncytial virus infection in a bone marrow transplant unit: effect on engraftment and outcome of pneumonia without specific antiviral treatment

Amphotericin B lipid complex (ABLC) for the treatment of confirmed or presumed fungal infections in immunocompromised patients with hematologic malignancies

Allogeneic stem cell transplantation for patients with congenital amegakaryocytic thrombocytopenia (CAT)

Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe

Acute pneumatosis cystoides intestinalis following allogeneic transplantation -the surgeon's dilemma

FAQs

Bone Marrow Transplantation has an SJR of 1,709 (best quartile Q1) in the CountryOfPapers database.

Immediate OA APC is 3580 EUR. Non-OA / submission fee is 0 EUR.

The acceptance rate recorded for Bone Marrow Transplantation is 22%.

Bone Marrow Transplantation

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Bone Marrow Transplantation?

What is the APC / publication cost?

What is the acceptance rate?